nodes	percent_of_prediction	percent_of_DWPC	metapath
Lenalidomide—PTGS2—stomach cancer	0.312	1	CbGaD
Lenalidomide—ABCB1—Mitomycin—stomach cancer	0.0927	0.581	CbGbCtD
Lenalidomide—ABCB1—Irinotecan—stomach cancer	0.0238	0.149	CbGbCtD
Lenalidomide—ABCB1—Docetaxel—stomach cancer	0.0174	0.109	CbGbCtD
Lenalidomide—ABCB1—Doxorubicin—stomach cancer	0.013	0.0814	CbGbCtD
Lenalidomide—ABCB1—Methotrexate—stomach cancer	0.0126	0.0789	CbGbCtD
Lenalidomide—CDH5—blood vessel—stomach cancer	0.0106	0.104	CbGeAlD
Lenalidomide—TNFSF11—hematopoietic system—stomach cancer	0.00747	0.0736	CbGeAlD
Lenalidomide—CDH5—hematopoietic system—stomach cancer	0.00562	0.0554	CbGeAlD
Lenalidomide—TNFSF11—lymphoid tissue—stomach cancer	0.00526	0.0518	CbGeAlD
Lenalidomide—CDH5—epithelium—stomach cancer	0.00514	0.0506	CbGeAlD
Lenalidomide—CDH5—smooth muscle tissue—stomach cancer	0.00495	0.0488	CbGeAlD
Lenalidomide—TNFSF11—bone marrow—stomach cancer	0.00479	0.0472	CbGeAlD
Lenalidomide—TNFSF11—endocrine gland—stomach cancer	0.00429	0.0423	CbGeAlD
Lenalidomide—CDH5—lymphoid tissue—stomach cancer	0.00396	0.039	CbGeAlD
Lenalidomide—CDH5—bone marrow—stomach cancer	0.0036	0.0355	CbGeAlD
Lenalidomide—CRBN—hematopoietic system—stomach cancer	0.00357	0.0352	CbGeAlD
Lenalidomide—Thalidomide—FGFR2—stomach cancer	0.0034	0.452	CrCbGaD
Lenalidomide—CDH5—endocrine gland—stomach cancer	0.00323	0.0318	CbGeAlD
Lenalidomide—TNFSF11—lymph node—stomach cancer	0.00297	0.0293	CbGeAlD
Lenalidomide—CDH5—liver—stomach cancer	0.00291	0.0287	CbGeAlD
Lenalidomide—CRBN—pancreas—stomach cancer	0.00291	0.0287	CbGeAlD
Lenalidomide—CRBN—lymphoid tissue—stomach cancer	0.00251	0.0248	CbGeAlD
Lenalidomide—CRBN—digestive system—stomach cancer	0.00248	0.0245	CbGeAlD
Lenalidomide—CRBN—bone marrow—stomach cancer	0.00229	0.0226	CbGeAlD
Lenalidomide—CDH5—lymph node—stomach cancer	0.00223	0.022	CbGeAlD
Lenalidomide—CRBN—endocrine gland—stomach cancer	0.00205	0.0202	CbGeAlD
Lenalidomide—CRBN—liver—stomach cancer	0.00185	0.0182	CbGeAlD
Lenalidomide—PTGS2—blood vessel—stomach cancer	0.00183	0.018	CbGeAlD
Lenalidomide—PTGS2—gall bladder—stomach cancer	0.00172	0.0169	CbGeAlD
Lenalidomide—Pomalidomide—TNF—stomach cancer	0.0017	0.226	CrCbGaD
Lenalidomide—CRBN—lymph node—stomach cancer	0.00142	0.014	CbGeAlD
Lenalidomide—ABCB1—blood vessel—stomach cancer	0.00113	0.0111	CbGeAlD
Lenalidomide—Thalidomide—TNF—stomach cancer	0.0011	0.146	CrCbGaD
Lenalidomide—PTGS2—hematopoietic system—stomach cancer	0.000972	0.00958	CbGeAlD
Lenalidomide—PTGS2—epithelium—stomach cancer	0.000889	0.00876	CbGeAlD
Lenalidomide—PTGS2—smooth muscle tissue—stomach cancer	0.000856	0.00844	CbGeAlD
Lenalidomide—Pomalidomide—PTGS2—stomach cancer	0.000809	0.107	CrCbGaD
Lenalidomide—PTGS2—pancreas—stomach cancer	0.000792	0.0078	CbGeAlD
Lenalidomide—PTGS2—lymphoid tissue—stomach cancer	0.000684	0.00675	CbGeAlD
Lenalidomide—PTGS2—digestive system—stomach cancer	0.000676	0.00666	CbGeAlD
Lenalidomide—PTGS2—bone marrow—stomach cancer	0.000623	0.00614	CbGeAlD
Lenalidomide—ABCB1—hematopoietic system—stomach cancer	0.000601	0.00593	CbGeAlD
Lenalidomide—PTGS2—endocrine gland—stomach cancer	0.000559	0.00551	CbGeAlD
Lenalidomide—ABCB1—epithelium—stomach cancer	0.00055	0.00542	CbGeAlD
Lenalidomide—Thalidomide—PTGS2—stomach cancer	0.000521	0.0692	CrCbGaD
Lenalidomide—PTGS2—liver—stomach cancer	0.000504	0.00497	CbGeAlD
Lenalidomide—ABCB1—pancreas—stomach cancer	0.00049	0.00483	CbGeAlD
Lenalidomide—ABCB1—lymphoid tissue—stomach cancer	0.000423	0.00417	CbGeAlD
Lenalidomide—ABCB1—digestive system—stomach cancer	0.000418	0.00412	CbGeAlD
Lenalidomide—PTGS2—lymph node—stomach cancer	0.000386	0.00381	CbGeAlD
Lenalidomide—ABCB1—bone marrow—stomach cancer	0.000385	0.0038	CbGeAlD
Lenalidomide—ABCB1—endocrine gland—stomach cancer	0.000346	0.00341	CbGeAlD
Lenalidomide—ABCB1—liver—stomach cancer	0.000312	0.00307	CbGeAlD
Lenalidomide—ABCB1—lymph node—stomach cancer	0.000239	0.00235	CbGeAlD
Lenalidomide—Hepatitis—Doxorubicin—stomach cancer	6.6e-05	0.000221	CcSEcCtD
Lenalidomide—Insomnia—Capecitabine—stomach cancer	6.58e-05	0.00022	CcSEcCtD
Lenalidomide—Hypoaesthesia—Doxorubicin—stomach cancer	6.56e-05	0.000219	CcSEcCtD
Lenalidomide—Rash—Fluorouracil—stomach cancer	6.56e-05	0.000219	CcSEcCtD
Lenalidomide—Dermatitis—Fluorouracil—stomach cancer	6.56e-05	0.000219	CcSEcCtD
Lenalidomide—Pharyngitis—Doxorubicin—stomach cancer	6.55e-05	0.000219	CcSEcCtD
Lenalidomide—Paraesthesia—Capecitabine—stomach cancer	6.53e-05	0.000218	CcSEcCtD
Lenalidomide—Decreased appetite—Docetaxel—stomach cancer	6.53e-05	0.000218	CcSEcCtD
Lenalidomide—Headache—Fluorouracil—stomach cancer	6.52e-05	0.000218	CcSEcCtD
Lenalidomide—Urinary tract disorder—Doxorubicin—stomach cancer	6.52e-05	0.000218	CcSEcCtD
Lenalidomide—Oedema peripheral—Doxorubicin—stomach cancer	6.5e-05	0.000217	CcSEcCtD
Lenalidomide—Dysgeusia—Methotrexate—stomach cancer	6.5e-05	0.000217	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Docetaxel—stomach cancer	6.48e-05	0.000217	CcSEcCtD
Lenalidomide—Connective tissue disorder—Doxorubicin—stomach cancer	6.48e-05	0.000217	CcSEcCtD
Lenalidomide—Dyspnoea—Capecitabine—stomach cancer	6.48e-05	0.000217	CcSEcCtD
Lenalidomide—Fatigue—Docetaxel—stomach cancer	6.48e-05	0.000216	CcSEcCtD
Lenalidomide—Angiopathy—Epirubicin—stomach cancer	6.47e-05	0.000216	CcSEcCtD
Lenalidomide—Urethral disorder—Doxorubicin—stomach cancer	6.47e-05	0.000216	CcSEcCtD
Lenalidomide—Nausea—Irinotecan—stomach cancer	6.45e-05	0.000216	CcSEcCtD
Lenalidomide—Immune system disorder—Epirubicin—stomach cancer	6.44e-05	0.000215	CcSEcCtD
Lenalidomide—Mediastinal disorder—Epirubicin—stomach cancer	6.43e-05	0.000215	CcSEcCtD
Lenalidomide—Pain—Docetaxel—stomach cancer	6.42e-05	0.000215	CcSEcCtD
Lenalidomide—Constipation—Docetaxel—stomach cancer	6.42e-05	0.000215	CcSEcCtD
Lenalidomide—Back pain—Methotrexate—stomach cancer	6.42e-05	0.000215	CcSEcCtD
Lenalidomide—Dyspepsia—Capecitabine—stomach cancer	6.4e-05	0.000214	CcSEcCtD
Lenalidomide—Chills—Epirubicin—stomach cancer	6.4e-05	0.000214	CcSEcCtD
Lenalidomide—Arrhythmia—Epirubicin—stomach cancer	6.37e-05	0.000213	CcSEcCtD
Lenalidomide—Visual impairment—Doxorubicin—stomach cancer	6.36e-05	0.000213	CcSEcCtD
Lenalidomide—Decreased appetite—Capecitabine—stomach cancer	6.32e-05	0.000211	CcSEcCtD
Lenalidomide—Alopecia—Epirubicin—stomach cancer	6.3e-05	0.000211	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Capecitabine—stomach cancer	6.28e-05	0.00021	CcSEcCtD
Lenalidomide—Fatigue—Capecitabine—stomach cancer	6.27e-05	0.00021	CcSEcCtD
Lenalidomide—Vision blurred—Methotrexate—stomach cancer	6.25e-05	0.000209	CcSEcCtD
Lenalidomide—Mental disorder—Epirubicin—stomach cancer	6.25e-05	0.000209	CcSEcCtD
Lenalidomide—Erythema multiforme—Doxorubicin—stomach cancer	6.24e-05	0.000209	CcSEcCtD
Lenalidomide—Pain—Capecitabine—stomach cancer	6.22e-05	0.000208	CcSEcCtD
Lenalidomide—Constipation—Capecitabine—stomach cancer	6.22e-05	0.000208	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—APOA1—stomach cancer	6.22e-05	0.000519	CbGpPWpGaD
Lenalidomide—Malnutrition—Epirubicin—stomach cancer	6.21e-05	0.000208	CcSEcCtD
Lenalidomide—Erythema—Epirubicin—stomach cancer	6.21e-05	0.000208	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—FADS1—stomach cancer	6.2e-05	0.000517	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Docetaxel—stomach cancer	6.19e-05	0.000207	CcSEcCtD
Lenalidomide—Nausea—Fluorouracil—stomach cancer	6.18e-05	0.000207	CcSEcCtD
Lenalidomide—Eye disorder—Doxorubicin—stomach cancer	6.17e-05	0.000206	CcSEcCtD
Lenalidomide—Ill-defined disorder—Methotrexate—stomach cancer	6.15e-05	0.000206	CcSEcCtD
Lenalidomide—Tinnitus—Doxorubicin—stomach cancer	6.15e-05	0.000206	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Docetaxel—stomach cancer	6.14e-05	0.000205	CcSEcCtD
Lenalidomide—Anaemia—Methotrexate—stomach cancer	6.13e-05	0.000205	CcSEcCtD
Lenalidomide—Cardiac disorder—Doxorubicin—stomach cancer	6.12e-05	0.000205	CcSEcCtD
Lenalidomide—Flushing—Doxorubicin—stomach cancer	6.12e-05	0.000205	CcSEcCtD
Lenalidomide—Flatulence—Epirubicin—stomach cancer	6.12e-05	0.000204	CcSEcCtD
Lenalidomide—Tension—Epirubicin—stomach cancer	6.09e-05	0.000204	CcSEcCtD
Lenalidomide—Dysgeusia—Epirubicin—stomach cancer	6.08e-05	0.000203	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—RHOA—stomach cancer	6.07e-05	0.000506	CbGpPWpGaD
Lenalidomide—Nervousness—Epirubicin—stomach cancer	6.03e-05	0.000202	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—GMPR2—stomach cancer	6.01e-05	0.000502	CbGpPWpGaD
Lenalidomide—Back pain—Epirubicin—stomach cancer	6e-05	0.000201	CcSEcCtD
Lenalidomide—Feeling abnormal—Capecitabine—stomach cancer	5.99e-05	0.0002	CcSEcCtD
Lenalidomide—Angiopathy—Doxorubicin—stomach cancer	5.99e-05	0.0002	CcSEcCtD
Lenalidomide—Malaise—Methotrexate—stomach cancer	5.98e-05	0.0002	CcSEcCtD
Lenalidomide—Muscle spasms—Epirubicin—stomach cancer	5.97e-05	0.0002	CcSEcCtD
Lenalidomide—Immune system disorder—Doxorubicin—stomach cancer	5.96e-05	0.000199	CcSEcCtD
Lenalidomide—Vertigo—Methotrexate—stomach cancer	5.96e-05	0.000199	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Capecitabine—stomach cancer	5.95e-05	0.000199	CcSEcCtD
Lenalidomide—Mediastinal disorder—Doxorubicin—stomach cancer	5.95e-05	0.000199	CcSEcCtD
Lenalidomide—Abdominal pain—Docetaxel—stomach cancer	5.94e-05	0.000199	CcSEcCtD
Lenalidomide—Body temperature increased—Docetaxel—stomach cancer	5.94e-05	0.000199	CcSEcCtD
Lenalidomide—Leukopenia—Methotrexate—stomach cancer	5.94e-05	0.000199	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—PRKCB—stomach cancer	5.93e-05	0.000495	CbGpPWpGaD
Lenalidomide—Chills—Doxorubicin—stomach cancer	5.92e-05	0.000198	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL6ST—stomach cancer	5.91e-05	0.000493	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CHEK2—stomach cancer	5.9e-05	0.000492	CbGpPWpGaD
Lenalidomide—Arrhythmia—Doxorubicin—stomach cancer	5.89e-05	0.000197	CcSEcCtD
Lenalidomide—Vision blurred—Epirubicin—stomach cancer	5.85e-05	0.000196	CcSEcCtD
Lenalidomide—Alopecia—Doxorubicin—stomach cancer	5.83e-05	0.000195	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—SREBF2—stomach cancer	5.8e-05	0.000484	CbGpPWpGaD
Lenalidomide—Cough—Methotrexate—stomach cancer	5.79e-05	0.000194	CcSEcCtD
Lenalidomide—Mental disorder—Doxorubicin—stomach cancer	5.78e-05	0.000193	CcSEcCtD
Lenalidomide—Urticaria—Capecitabine—stomach cancer	5.78e-05	0.000193	CcSEcCtD
Lenalidomide—Ill-defined disorder—Epirubicin—stomach cancer	5.76e-05	0.000193	CcSEcCtD
Lenalidomide—Body temperature increased—Capecitabine—stomach cancer	5.75e-05	0.000192	CcSEcCtD
Lenalidomide—Abdominal pain—Capecitabine—stomach cancer	5.75e-05	0.000192	CcSEcCtD
Lenalidomide—Erythema—Doxorubicin—stomach cancer	5.74e-05	0.000192	CcSEcCtD
Lenalidomide—Malnutrition—Doxorubicin—stomach cancer	5.74e-05	0.000192	CcSEcCtD
Lenalidomide—Anaemia—Epirubicin—stomach cancer	5.74e-05	0.000192	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—RORA—stomach cancer	5.74e-05	0.000479	CbGpPWpGaD
Lenalidomide—Agitation—Epirubicin—stomach cancer	5.7e-05	0.000191	CcSEcCtD
Lenalidomide—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—stomach cancer	5.7e-05	0.000476	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—APC—stomach cancer	5.67e-05	0.000473	CbGpPWpGaD
Lenalidomide—Flatulence—Doxorubicin—stomach cancer	5.66e-05	0.000189	CcSEcCtD
Lenalidomide—Myalgia—Methotrexate—stomach cancer	5.65e-05	0.000189	CcSEcCtD
Lenalidomide—Chest pain—Methotrexate—stomach cancer	5.65e-05	0.000189	CcSEcCtD
Lenalidomide—Arthralgia—Methotrexate—stomach cancer	5.65e-05	0.000189	CcSEcCtD
Lenalidomide—Tension—Doxorubicin—stomach cancer	5.64e-05	0.000188	CcSEcCtD
Lenalidomide—Dysgeusia—Doxorubicin—stomach cancer	5.62e-05	0.000188	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—stomach cancer	5.61e-05	0.000187	CcSEcCtD
Lenalidomide—Malaise—Epirubicin—stomach cancer	5.6e-05	0.000187	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—JUN—stomach cancer	5.59e-05	0.000466	CbGpPWpGaD
Lenalidomide—Discomfort—Methotrexate—stomach cancer	5.58e-05	0.000187	CcSEcCtD
Lenalidomide—Nervousness—Doxorubicin—stomach cancer	5.58e-05	0.000187	CcSEcCtD
Lenalidomide—Vertigo—Epirubicin—stomach cancer	5.58e-05	0.000186	CcSEcCtD
Lenalidomide—Syncope—Epirubicin—stomach cancer	5.57e-05	0.000186	CcSEcCtD
Lenalidomide—Leukopenia—Epirubicin—stomach cancer	5.56e-05	0.000186	CcSEcCtD
Lenalidomide—Back pain—Doxorubicin—stomach cancer	5.56e-05	0.000186	CcSEcCtD
Lenalidomide—Hypersensitivity—Docetaxel—stomach cancer	5.53e-05	0.000185	CcSEcCtD
Lenalidomide—Muscle spasms—Doxorubicin—stomach cancer	5.52e-05	0.000185	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—IDH3B—stomach cancer	5.5e-05	0.000459	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SUCLG1—stomach cancer	5.5e-05	0.000459	CbGpPWpGaD
Lenalidomide—Palpitations—Epirubicin—stomach cancer	5.49e-05	0.000183	CcSEcCtD
Lenalidomide—Confusional state—Methotrexate—stomach cancer	5.46e-05	0.000182	CcSEcCtD
Lenalidomide—Loss of consciousness—Epirubicin—stomach cancer	5.46e-05	0.000182	CcSEcCtD
Lenalidomide—PTGS2—Disease—PGLS—stomach cancer	5.44e-05	0.000454	CbGpPWpGaD
Lenalidomide—Cough—Epirubicin—stomach cancer	5.42e-05	0.000181	CcSEcCtD
Lenalidomide—Vision blurred—Doxorubicin—stomach cancer	5.41e-05	0.000181	CcSEcCtD
Lenalidomide—Asthenia—Docetaxel—stomach cancer	5.39e-05	0.00018	CcSEcCtD
Lenalidomide—Infection—Methotrexate—stomach cancer	5.38e-05	0.00018	CcSEcCtD
Lenalidomide—Hypertension—Epirubicin—stomach cancer	5.36e-05	0.000179	CcSEcCtD
Lenalidomide—Hypersensitivity—Capecitabine—stomach cancer	5.36e-05	0.000179	CcSEcCtD
Lenalidomide—Ill-defined disorder—Doxorubicin—stomach cancer	5.33e-05	0.000178	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—CXCL8—stomach cancer	5.33e-05	0.000445	CbGpPWpGaD
Lenalidomide—Pruritus—Docetaxel—stomach cancer	5.31e-05	0.000178	CcSEcCtD
Lenalidomide—Nervous system disorder—Methotrexate—stomach cancer	5.31e-05	0.000177	CcSEcCtD
Lenalidomide—Anaemia—Doxorubicin—stomach cancer	5.31e-05	0.000177	CcSEcCtD
Lenalidomide—Thrombocytopenia—Methotrexate—stomach cancer	5.3e-05	0.000177	CcSEcCtD
Lenalidomide—Arthralgia—Epirubicin—stomach cancer	5.28e-05	0.000177	CcSEcCtD
Lenalidomide—Chest pain—Epirubicin—stomach cancer	5.28e-05	0.000177	CcSEcCtD
Lenalidomide—Myalgia—Epirubicin—stomach cancer	5.28e-05	0.000177	CcSEcCtD
Lenalidomide—Agitation—Doxorubicin—stomach cancer	5.28e-05	0.000176	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—IL6R—stomach cancer	5.27e-05	0.00044	CbGpPWpGaD
Lenalidomide—Anxiety—Epirubicin—stomach cancer	5.27e-05	0.000176	CcSEcCtD
Lenalidomide—Skin disorder—Methotrexate—stomach cancer	5.26e-05	0.000176	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—stomach cancer	5.25e-05	0.000175	CcSEcCtD
Lenalidomide—Hyperhidrosis—Methotrexate—stomach cancer	5.23e-05	0.000175	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	5.23e-05	0.000436	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—MYC—stomach cancer	5.23e-05	0.000436	CbGpPWpGaD
Lenalidomide—Discomfort—Epirubicin—stomach cancer	5.22e-05	0.000175	CcSEcCtD
Lenalidomide—Asthenia—Capecitabine—stomach cancer	5.22e-05	0.000174	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—CXCL8—stomach cancer	5.21e-05	0.000434	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—CDKN1B—stomach cancer	5.2e-05	0.000434	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RBP1—stomach cancer	5.19e-05	0.000433	CbGpPWpGaD
Lenalidomide—Malaise—Doxorubicin—stomach cancer	5.18e-05	0.000173	CcSEcCtD
Lenalidomide—Dry mouth—Epirubicin—stomach cancer	5.17e-05	0.000173	CcSEcCtD
Lenalidomide—Vertigo—Doxorubicin—stomach cancer	5.16e-05	0.000173	CcSEcCtD
Lenalidomide—Anorexia—Methotrexate—stomach cancer	5.16e-05	0.000173	CcSEcCtD
Lenalidomide—Syncope—Doxorubicin—stomach cancer	5.15e-05	0.000172	CcSEcCtD
Lenalidomide—Pruritus—Capecitabine—stomach cancer	5.14e-05	0.000172	CcSEcCtD
Lenalidomide—Leukopenia—Doxorubicin—stomach cancer	5.14e-05	0.000172	CcSEcCtD
Lenalidomide—Diarrhoea—Docetaxel—stomach cancer	5.14e-05	0.000172	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL1B—stomach cancer	5.11e-05	0.000427	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NDUFS1—stomach cancer	5.11e-05	0.000427	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NDUFV1—stomach cancer	5.11e-05	0.000427	CbGpPWpGaD
Lenalidomide—Confusional state—Epirubicin—stomach cancer	5.11e-05	0.000171	CcSEcCtD
Lenalidomide—Palpitations—Doxorubicin—stomach cancer	5.08e-05	0.00017	CcSEcCtD
Lenalidomide—Oedema—Epirubicin—stomach cancer	5.07e-05	0.000169	CcSEcCtD
Lenalidomide—Hypotension—Methotrexate—stomach cancer	5.06e-05	0.000169	CcSEcCtD
Lenalidomide—Loss of consciousness—Doxorubicin—stomach cancer	5.05e-05	0.000169	CcSEcCtD
Lenalidomide—Infection—Epirubicin—stomach cancer	5.03e-05	0.000168	CcSEcCtD
Lenalidomide—Cough—Doxorubicin—stomach cancer	5.01e-05	0.000168	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALOX5—stomach cancer	5e-05	0.000417	CbGpPWpGaD
Lenalidomide—ABCB1—Allograft Rejection—IL1B—stomach cancer	5e-05	0.000417	CbGpPWpGaD
Lenalidomide—Shock—Epirubicin—stomach cancer	4.98e-05	0.000167	CcSEcCtD
Lenalidomide—Diarrhoea—Capecitabine—stomach cancer	4.98e-05	0.000166	CcSEcCtD
Lenalidomide—Nervous system disorder—Epirubicin—stomach cancer	4.97e-05	0.000166	CcSEcCtD
Lenalidomide—Dizziness—Docetaxel—stomach cancer	4.97e-05	0.000166	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—CCND1—stomach cancer	4.96e-05	0.000414	CbGpPWpGaD
Lenalidomide—Thrombocytopenia—Epirubicin—stomach cancer	4.96e-05	0.000166	CcSEcCtD
Lenalidomide—Hypertension—Doxorubicin—stomach cancer	4.96e-05	0.000166	CcSEcCtD
Lenalidomide—Tachycardia—Epirubicin—stomach cancer	4.94e-05	0.000165	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—SERPINE1—stomach cancer	4.93e-05	0.000412	CbGpPWpGaD
Lenalidomide—Musculoskeletal discomfort—Methotrexate—stomach cancer	4.93e-05	0.000165	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—BDNF—stomach cancer	4.92e-05	0.000411	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	4.92e-05	0.000411	CbGpPWpGaD
Lenalidomide—Skin disorder—Epirubicin—stomach cancer	4.92e-05	0.000165	CcSEcCtD
Lenalidomide—Hyperhidrosis—Epirubicin—stomach cancer	4.9e-05	0.000164	CcSEcCtD
Lenalidomide—Insomnia—Methotrexate—stomach cancer	4.9e-05	0.000164	CcSEcCtD
Lenalidomide—Arthralgia—Doxorubicin—stomach cancer	4.89e-05	0.000163	CcSEcCtD
Lenalidomide—Myalgia—Doxorubicin—stomach cancer	4.89e-05	0.000163	CcSEcCtD
Lenalidomide—Chest pain—Doxorubicin—stomach cancer	4.89e-05	0.000163	CcSEcCtD
Lenalidomide—ABCB1—HIF-1-alpha transcription factor network—VEGFA—stomach cancer	4.88e-05	0.000407	CbGpPWpGaD
Lenalidomide—Anxiety—Doxorubicin—stomach cancer	4.87e-05	0.000163	CcSEcCtD
Lenalidomide—Paraesthesia—Methotrexate—stomach cancer	4.86e-05	0.000163	CcSEcCtD
Lenalidomide—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—stomach cancer	4.86e-05	0.000162	CcSEcCtD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—SMAD4—stomach cancer	4.84e-05	0.000404	CbGpPWpGaD
Lenalidomide—Discomfort—Doxorubicin—stomach cancer	4.83e-05	0.000162	CcSEcCtD
Lenalidomide—PTGS2—C-MYB transcription factor network—KRAS—stomach cancer	4.83e-05	0.000403	CbGpPWpGaD
Lenalidomide—Anorexia—Epirubicin—stomach cancer	4.83e-05	0.000161	CcSEcCtD
Lenalidomide—Dyspnoea—Methotrexate—stomach cancer	4.83e-05	0.000161	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MMP9—stomach cancer	4.82e-05	0.000402	CbGpPWpGaD
Lenalidomide—Somnolence—Methotrexate—stomach cancer	4.81e-05	0.000161	CcSEcCtD
Lenalidomide—Dizziness—Capecitabine—stomach cancer	4.81e-05	0.000161	CcSEcCtD
Lenalidomide—Dry mouth—Doxorubicin—stomach cancer	4.78e-05	0.00016	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—ACAD8—stomach cancer	4.78e-05	0.000399	CbGpPWpGaD
Lenalidomide—Vomiting—Docetaxel—stomach cancer	4.78e-05	0.00016	CcSEcCtD
Lenalidomide—Dyspepsia—Methotrexate—stomach cancer	4.77e-05	0.000159	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—RHOA—stomach cancer	4.76e-05	0.000397	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—stomach cancer	4.75e-05	0.000397	CbGpPWpGaD
Lenalidomide—Rash—Docetaxel—stomach cancer	4.74e-05	0.000158	CcSEcCtD
Lenalidomide—Hypotension—Epirubicin—stomach cancer	4.73e-05	0.000158	CcSEcCtD
Lenalidomide—Dermatitis—Docetaxel—stomach cancer	4.73e-05	0.000158	CcSEcCtD
Lenalidomide—Confusional state—Doxorubicin—stomach cancer	4.73e-05	0.000158	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—NOS3—stomach cancer	4.71e-05	0.000393	CbGpPWpGaD
Lenalidomide—Decreased appetite—Methotrexate—stomach cancer	4.71e-05	0.000157	CcSEcCtD
Lenalidomide—Headache—Docetaxel—stomach cancer	4.71e-05	0.000157	CcSEcCtD
Lenalidomide—PTGS2—Selenium Micronutrient Network—TNF—stomach cancer	4.69e-05	0.000391	CbGpPWpGaD
Lenalidomide—Oedema—Doxorubicin—stomach cancer	4.69e-05	0.000157	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Methotrexate—stomach cancer	4.67e-05	0.000156	CcSEcCtD
Lenalidomide—Fatigue—Methotrexate—stomach cancer	4.67e-05	0.000156	CcSEcCtD
Lenalidomide—Infection—Doxorubicin—stomach cancer	4.66e-05	0.000156	CcSEcCtD
Lenalidomide—Pain—Methotrexate—stomach cancer	4.63e-05	0.000155	CcSEcCtD
Lenalidomide—PTGS2—Disease—FBP1—stomach cancer	4.63e-05	0.000386	CbGpPWpGaD
Lenalidomide—Vomiting—Capecitabine—stomach cancer	4.62e-05	0.000155	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Epirubicin—stomach cancer	4.62e-05	0.000154	CcSEcCtD
Lenalidomide—Shock—Doxorubicin—stomach cancer	4.61e-05	0.000154	CcSEcCtD
Lenalidomide—Nervous system disorder—Doxorubicin—stomach cancer	4.6e-05	0.000154	CcSEcCtD
Lenalidomide—Thrombocytopenia—Doxorubicin—stomach cancer	4.59e-05	0.000153	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	4.59e-05	0.000383	CbGpPWpGaD
Lenalidomide—Rash—Capecitabine—stomach cancer	4.59e-05	0.000153	CcSEcCtD
Lenalidomide—Insomnia—Epirubicin—stomach cancer	4.58e-05	0.000153	CcSEcCtD
Lenalidomide—Dermatitis—Capecitabine—stomach cancer	4.58e-05	0.000153	CcSEcCtD
Lenalidomide—Tachycardia—Doxorubicin—stomach cancer	4.57e-05	0.000153	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—BLVRB—stomach cancer	4.56e-05	0.00038	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PGLS—stomach cancer	4.56e-05	0.00038	CbGpPWpGaD
Lenalidomide—Headache—Capecitabine—stomach cancer	4.56e-05	0.000152	CcSEcCtD
Lenalidomide—Skin disorder—Doxorubicin—stomach cancer	4.55e-05	0.000152	CcSEcCtD
Lenalidomide—Paraesthesia—Epirubicin—stomach cancer	4.55e-05	0.000152	CcSEcCtD
Lenalidomide—Hyperhidrosis—Doxorubicin—stomach cancer	4.53e-05	0.000152	CcSEcCtD
Lenalidomide—Dyspnoea—Epirubicin—stomach cancer	4.52e-05	0.000151	CcSEcCtD
Lenalidomide—Somnolence—Epirubicin—stomach cancer	4.5e-05	0.000151	CcSEcCtD
Lenalidomide—Anorexia—Doxorubicin—stomach cancer	4.47e-05	0.000149	CcSEcCtD
Lenalidomide—Nausea—Docetaxel—stomach cancer	4.46e-05	0.000149	CcSEcCtD
Lenalidomide—Feeling abnormal—Methotrexate—stomach cancer	4.46e-05	0.000149	CcSEcCtD
Lenalidomide—Dyspepsia—Epirubicin—stomach cancer	4.46e-05	0.000149	CcSEcCtD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—SLC1A2—stomach cancer	4.44e-05	0.000371	CbGpPWpGaD
Lenalidomide—Gastrointestinal pain—Methotrexate—stomach cancer	4.43e-05	0.000148	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—ERBB2—stomach cancer	4.41e-05	0.000368	CbGpPWpGaD
Lenalidomide—Decreased appetite—Epirubicin—stomach cancer	4.4e-05	0.000147	CcSEcCtD
Lenalidomide—Hypotension—Doxorubicin—stomach cancer	4.38e-05	0.000146	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Epirubicin—stomach cancer	4.37e-05	0.000146	CcSEcCtD
Lenalidomide—Fatigue—Epirubicin—stomach cancer	4.37e-05	0.000146	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PPAP2A—stomach cancer	4.35e-05	0.000363	CbGpPWpGaD
Lenalidomide—Constipation—Epirubicin—stomach cancer	4.33e-05	0.000145	CcSEcCtD
Lenalidomide—Pain—Epirubicin—stomach cancer	4.33e-05	0.000145	CcSEcCtD
Lenalidomide—Nausea—Capecitabine—stomach cancer	4.32e-05	0.000144	CcSEcCtD
Lenalidomide—Urticaria—Methotrexate—stomach cancer	4.3e-05	0.000144	CcSEcCtD
Lenalidomide—Abdominal pain—Methotrexate—stomach cancer	4.28e-05	0.000143	CcSEcCtD
Lenalidomide—Body temperature increased—Methotrexate—stomach cancer	4.28e-05	0.000143	CcSEcCtD
Lenalidomide—Musculoskeletal discomfort—Doxorubicin—stomach cancer	4.27e-05	0.000143	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—GMPR2—stomach cancer	4.26e-05	0.000356	CbGpPWpGaD
Lenalidomide—Insomnia—Doxorubicin—stomach cancer	4.24e-05	0.000142	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—VEGFA—stomach cancer	4.23e-05	0.000353	CbGpPWpGaD
Lenalidomide—Paraesthesia—Doxorubicin—stomach cancer	4.21e-05	0.000141	CcSEcCtD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—AKR1C3—stomach cancer	4.18e-05	0.000349	CbGpPWpGaD
Lenalidomide—Dyspnoea—Doxorubicin—stomach cancer	4.18e-05	0.00014	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—CXCL8—stomach cancer	4.18e-05	0.000349	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Epirubicin—stomach cancer	4.17e-05	0.00014	CcSEcCtD
Lenalidomide—Somnolence—Doxorubicin—stomach cancer	4.17e-05	0.000139	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Epirubicin—stomach cancer	4.14e-05	0.000139	CcSEcCtD
Lenalidomide—Dyspepsia—Doxorubicin—stomach cancer	4.13e-05	0.000138	CcSEcCtD
Lenalidomide—PTGS2—Disease—PGAM1—stomach cancer	4.12e-05	0.000344	CbGpPWpGaD
Lenalidomide—PTGS2—C-MYB transcription factor network—HRAS—stomach cancer	4.1e-05	0.000342	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MAPK3—stomach cancer	4.09e-05	0.000342	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CDKN1B—stomach cancer	4.08e-05	0.00034	CbGpPWpGaD
Lenalidomide—Decreased appetite—Doxorubicin—stomach cancer	4.07e-05	0.000136	CcSEcCtD
Lenalidomide—Gastrointestinal disorder—Doxorubicin—stomach cancer	4.05e-05	0.000135	CcSEcCtD
Lenalidomide—Fatigue—Doxorubicin—stomach cancer	4.04e-05	0.000135	CcSEcCtD
Lenalidomide—Urticaria—Epirubicin—stomach cancer	4.02e-05	0.000135	CcSEcCtD
Lenalidomide—Pain—Doxorubicin—stomach cancer	4.01e-05	0.000134	CcSEcCtD
Lenalidomide—Constipation—Doxorubicin—stomach cancer	4.01e-05	0.000134	CcSEcCtD
Lenalidomide—Body temperature increased—Epirubicin—stomach cancer	4e-05	0.000134	CcSEcCtD
Lenalidomide—Abdominal pain—Epirubicin—stomach cancer	4e-05	0.000134	CcSEcCtD
Lenalidomide—Hypersensitivity—Methotrexate—stomach cancer	3.99e-05	0.000133	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—MYC—stomach cancer	3.98e-05	0.000332	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—WIF1—stomach cancer	3.93e-05	0.000328	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—IDH3B—stomach cancer	3.9e-05	0.000325	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SUCLG1—stomach cancer	3.9e-05	0.000325	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—MAPK1—stomach cancer	3.9e-05	0.000325	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—EGFR—stomach cancer	3.89e-05	0.000325	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CCND1—stomach cancer	3.89e-05	0.000325	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—JUN—stomach cancer	3.88e-05	0.000324	CbGpPWpGaD
Lenalidomide—Asthenia—Methotrexate—stomach cancer	3.88e-05	0.00013	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CKB—stomach cancer	3.87e-05	0.000323	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CA1—stomach cancer	3.87e-05	0.000323	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NDUFA2—stomach cancer	3.87e-05	0.000323	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—FBP1—stomach cancer	3.87e-05	0.000323	CbGpPWpGaD
Lenalidomide—Feeling abnormal—Doxorubicin—stomach cancer	3.86e-05	0.000129	CcSEcCtD
Lenalidomide—Gastrointestinal pain—Doxorubicin—stomach cancer	3.83e-05	0.000128	CcSEcCtD
Lenalidomide—Pruritus—Methotrexate—stomach cancer	3.83e-05	0.000128	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	3.82e-05	0.000319	CbGpPWpGaD
Lenalidomide—PTGS2—Selenium Micronutrient Network—IL6—stomach cancer	3.79e-05	0.000316	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MMP9—stomach cancer	3.78e-05	0.000315	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—CDKN1A—stomach cancer	3.77e-05	0.000314	CbGpPWpGaD
Lenalidomide—Hypersensitivity—Epirubicin—stomach cancer	3.73e-05	0.000125	CcSEcCtD
Lenalidomide—Urticaria—Doxorubicin—stomach cancer	3.72e-05	0.000124	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—TNF—stomach cancer	3.71e-05	0.000309	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—stomach cancer	3.71e-05	0.000309	CbGpPWpGaD
Lenalidomide—Body temperature increased—Doxorubicin—stomach cancer	3.71e-05	0.000124	CcSEcCtD
Lenalidomide—Abdominal pain—Doxorubicin—stomach cancer	3.71e-05	0.000124	CcSEcCtD
Lenalidomide—Diarrhoea—Methotrexate—stomach cancer	3.7e-05	0.000124	CcSEcCtD
Lenalidomide—PTGS2—Disease—RPL18—stomach cancer	3.7e-05	0.000309	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPL13—stomach cancer	3.7e-05	0.000309	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAPK8—stomach cancer	3.68e-05	0.000307	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLIN2—stomach cancer	3.64e-05	0.000304	CbGpPWpGaD
Lenalidomide—Asthenia—Epirubicin—stomach cancer	3.63e-05	0.000122	CcSEcCtD
Lenalidomide—ABCB1—Allograft Rejection—TNF—stomach cancer	3.62e-05	0.000302	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NDUFV1—stomach cancer	3.62e-05	0.000302	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NDUFS1—stomach cancer	3.62e-05	0.000302	CbGpPWpGaD
Lenalidomide—Pruritus—Epirubicin—stomach cancer	3.58e-05	0.00012	CcSEcCtD
Lenalidomide—Dizziness—Methotrexate—stomach cancer	3.58e-05	0.00012	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—CA2—stomach cancer	3.54e-05	0.000296	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	3.54e-05	0.000295	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RNF43—stomach cancer	3.51e-05	0.000293	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—APC—stomach cancer	3.49e-05	0.000291	CbGpPWpGaD
Lenalidomide—Diarrhoea—Epirubicin—stomach cancer	3.47e-05	0.000116	CcSEcCtD
Lenalidomide—Hypersensitivity—Doxorubicin—stomach cancer	3.45e-05	0.000115	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—NT5E—stomach cancer	3.45e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PGAM1—stomach cancer	3.45e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPS15—stomach cancer	3.45e-05	0.000288	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPS21—stomach cancer	3.45e-05	0.000288	CbGpPWpGaD
Lenalidomide—Vomiting—Methotrexate—stomach cancer	3.44e-05	0.000115	CcSEcCtD
Lenalidomide—Rash—Methotrexate—stomach cancer	3.41e-05	0.000114	CcSEcCtD
Lenalidomide—Dermatitis—Methotrexate—stomach cancer	3.41e-05	0.000114	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—VEGFA—stomach cancer	3.39e-05	0.000283	CbGpPWpGaD
Lenalidomide—Headache—Methotrexate—stomach cancer	3.39e-05	0.000113	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	3.38e-05	0.000282	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	3.37e-05	0.000281	CbGpPWpGaD
Lenalidomide—Asthenia—Doxorubicin—stomach cancer	3.36e-05	0.000112	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—STAT3—stomach cancer	3.36e-05	0.00028	CbGpPWpGaD
Lenalidomide—Dizziness—Epirubicin—stomach cancer	3.35e-05	0.000112	CcSEcCtD
Lenalidomide—Pruritus—Doxorubicin—stomach cancer	3.32e-05	0.000111	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—ALDH7A1—stomach cancer	3.29e-05	0.000275	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PLCE1—stomach cancer	3.29e-05	0.000275	CbGpPWpGaD
Lenalidomide—PTGS2—Spinal Cord Injury—TP53—stomach cancer	3.27e-05	0.000273	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	3.27e-05	0.000273	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CASP8—stomach cancer	3.25e-05	0.000271	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PGLS—stomach cancer	3.23e-05	0.000269	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—BLVRB—stomach cancer	3.23e-05	0.000269	CbGpPWpGaD
Lenalidomide—Vomiting—Epirubicin—stomach cancer	3.22e-05	0.000108	CcSEcCtD
Lenalidomide—Nausea—Methotrexate—stomach cancer	3.22e-05	0.000108	CcSEcCtD
Lenalidomide—CDH5—Signaling Pathways—MAPK3—stomach cancer	3.21e-05	0.000268	CbGpPWpGaD
Lenalidomide—Diarrhoea—Doxorubicin—stomach cancer	3.21e-05	0.000107	CcSEcCtD
Lenalidomide—Rash—Epirubicin—stomach cancer	3.19e-05	0.000107	CcSEcCtD
Lenalidomide—Dermatitis—Epirubicin—stomach cancer	3.19e-05	0.000107	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	3.19e-05	0.000266	CbGpPWpGaD
Lenalidomide—Headache—Epirubicin—stomach cancer	3.17e-05	0.000106	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—UMPS—stomach cancer	3.16e-05	0.000264	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MYC—stomach cancer	3.12e-05	0.000261	CbGpPWpGaD
Lenalidomide—Dizziness—Doxorubicin—stomach cancer	3.1e-05	0.000104	CcSEcCtD
Lenalidomide—ABCB1—Metabolism—PPAP2A—stomach cancer	3.08e-05	0.000257	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—MAPK1—stomach cancer	3.05e-05	0.000255	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—EGFR—stomach cancer	3.05e-05	0.000255	CbGpPWpGaD
Lenalidomide—Nausea—Epirubicin—stomach cancer	3.01e-05	0.000101	CcSEcCtD
Lenalidomide—PTGS2—Spinal Cord Injury—IL6—stomach cancer	2.99e-05	0.00025	CbGpPWpGaD
Lenalidomide—Vomiting—Doxorubicin—stomach cancer	2.98e-05	9.96e-05	CcSEcCtD
Lenalidomide—Rash—Doxorubicin—stomach cancer	2.96e-05	9.88e-05	CcSEcCtD
Lenalidomide—Dermatitis—Doxorubicin—stomach cancer	2.95e-05	9.87e-05	CcSEcCtD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.94e-05	0.000246	CbGpPWpGaD
Lenalidomide—Headache—Doxorubicin—stomach cancer	2.94e-05	9.82e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—PDHA1—stomach cancer	2.94e-05	0.000245	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ECHS1—stomach cancer	2.94e-05	0.000245	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—KRAS—stomach cancer	2.89e-05	0.000241	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ALDOB—stomach cancer	2.86e-05	0.000238	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPL15—stomach cancer	2.8e-05	0.000234	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	2.79e-05	0.000232	CbGpPWpGaD
Lenalidomide—Nausea—Doxorubicin—stomach cancer	2.78e-05	9.31e-05	CcSEcCtD
Lenalidomide—PTGS2—Metabolism—TYMP—stomach cancer	2.76e-05	0.00023	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—FADS1—stomach cancer	2.76e-05	0.00023	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NPM1—stomach cancer	2.75e-05	0.00023	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NDUFA2—stomach cancer	2.75e-05	0.000229	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CA1—stomach cancer	2.75e-05	0.000229	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CKB—stomach cancer	2.75e-05	0.000229	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FBP1—stomach cancer	2.75e-05	0.000229	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—stomach cancer	2.71e-05	0.000226	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	2.71e-05	0.000226	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RBP4—stomach cancer	2.66e-05	0.000222	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—PIK3CA—stomach cancer	2.65e-05	0.000221	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	2.65e-05	0.000221	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—stomach cancer	2.65e-05	0.000221	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	2.65e-05	0.000221	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPS26—stomach cancer	2.61e-05	0.000218	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPIA—stomach cancer	2.59e-05	0.000216	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—SREBF2—stomach cancer	2.58e-05	0.000216	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLIN2—stomach cancer	2.58e-05	0.000215	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—TP53—stomach cancer	2.56e-05	0.000214	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—RORA—stomach cancer	2.55e-05	0.000213	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	2.52e-05	0.000211	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CA2—stomach cancer	2.51e-05	0.00021	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1B—stomach cancer	2.51e-05	0.000209	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	2.5e-05	0.000209	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—HRAS—stomach cancer	2.45e-05	0.000205	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NT5E—stomach cancer	2.45e-05	0.000204	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PGAM1—stomach cancer	2.45e-05	0.000204	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—stomach cancer	2.39e-05	0.0002	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALDOB—stomach cancer	2.39e-05	0.0002	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—JUN—stomach cancer	2.39e-05	0.000199	CbGpPWpGaD
Lenalidomide—CDH5—Signaling Pathways—IL6—stomach cancer	2.35e-05	0.000196	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PLCE1—stomach cancer	2.34e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDH7A1—stomach cancer	2.34e-05	0.000195	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—stomach cancer	2.32e-05	0.000193	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	2.3e-05	0.000192	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK8—stomach cancer	2.26e-05	0.000189	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—CAV1—stomach cancer	2.26e-05	0.000188	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—APOA1—stomach cancer	2.25e-05	0.000188	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—UMPS—stomach cancer	2.24e-05	0.000187	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALOX5—stomach cancer	2.23e-05	0.000186	CbGpPWpGaD
Lenalidomide—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	2.22e-05	0.000186	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPS19—stomach cancer	2.22e-05	0.000185	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—AKR1C3—stomach cancer	2.22e-05	0.000185	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—DPYD—stomach cancer	2.19e-05	0.000183	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ENO1—stomach cancer	2.17e-05	0.000181	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—stomach cancer	2.09e-05	0.000174	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PDHA1—stomach cancer	2.08e-05	0.000174	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ECHS1—stomach cancer	2.08e-05	0.000174	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—HMOX1—stomach cancer	2e-05	0.000167	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PPARG—stomach cancer	1.98e-05	0.000166	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—stomach cancer	1.97e-05	0.000165	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RPS6—stomach cancer	1.97e-05	0.000164	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TYMP—stomach cancer	1.96e-05	0.000163	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—FADS1—stomach cancer	1.96e-05	0.000163	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTT1—stomach cancer	1.94e-05	0.000162	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CD44—stomach cancer	1.92e-05	0.00016	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—stomach cancer	1.92e-05	0.00016	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CYP2A6—stomach cancer	1.91e-05	0.00016	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—stomach cancer	1.88e-05	0.000157	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—stomach cancer	1.88e-05	0.000157	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—AKR1C3—stomach cancer	1.86e-05	0.000155	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—SREBF2—stomach cancer	1.83e-05	0.000153	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ENO1—stomach cancer	1.81e-05	0.000151	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—RORA—stomach cancer	1.81e-05	0.000151	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HBEGF—stomach cancer	1.81e-05	0.000151	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—stomach cancer	1.79e-05	0.000149	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—ALB—stomach cancer	1.78e-05	0.000149	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—stomach cancer	1.77e-05	0.000148	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALDOB—stomach cancer	1.7e-05	0.000142	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PPP2R1A—stomach cancer	1.63e-05	0.000136	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—stomach cancer	1.63e-05	0.000136	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CD44—stomach cancer	1.61e-05	0.000134	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALOX5—stomach cancer	1.58e-05	0.000132	CbGpPWpGaD
Lenalidomide—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—stomach cancer	1.58e-05	0.000132	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—DPYD—stomach cancer	1.55e-05	0.000129	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—APOA1—stomach cancer	1.52e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SMAD4—stomach cancer	1.52e-05	0.000127	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FYN—stomach cancer	1.44e-05	0.00012	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ERCC2—stomach cancer	1.38e-05	0.000115	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTT1—stomach cancer	1.37e-05	0.000114	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPP2R1A—stomach cancer	1.37e-05	0.000114	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CYP2A6—stomach cancer	1.36e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—FGFR2—stomach cancer	1.35e-05	0.000113	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTP1—stomach cancer	1.34e-05	0.000112	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—HMOX1—stomach cancer	1.32e-05	0.00011	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—AKR1C3—stomach cancer	1.32e-05	0.00011	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MTHFR—stomach cancer	1.3e-05	0.000109	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ENO1—stomach cancer	1.29e-05	0.000107	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—TYMS—stomach cancer	1.25e-05	0.000104	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IRS2—stomach cancer	1.24e-05	0.000103	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—GSTM1—stomach cancer	1.23e-05	0.000103	CbGpPWpGaD
Lenalidomide—ABCB1—Transmembrane transport of small molecules—ALB—stomach cancer	1.2e-05	0.0001	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CAV1—stomach cancer	1.2e-05	0.0001	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APOA1—stomach cancer	1.2e-05	9.99e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ERCC2—stomach cancer	1.16e-05	9.67e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CD44—stomach cancer	1.14e-05	9.51e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6ST—stomach cancer	1.14e-05	9.49e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—APC—stomach cancer	1.09e-05	9.12e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—MTHFR—stomach cancer	1.09e-05	9.09e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6R—stomach cancer	1.02e-05	8.47e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—CAV1—stomach cancer	1.01e-05	8.39e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—APOA1—stomach cancer	1e-05	8.37e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPP2R1A—stomach cancer	9.7e-06	8.09e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—stomach cancer	9.6e-06	8.01e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTP1—stomach cancer	9.51e-06	7.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—SERPINE1—stomach cancer	9.51e-06	7.93e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—HMOX1—stomach cancer	9.38e-06	7.83e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—RHOA—stomach cancer	9.17e-06	7.65e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—NOS3—stomach cancer	9.07e-06	7.57e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—TYMS—stomach cancer	8.84e-06	7.38e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PPARG—stomach cancer	8.84e-06	7.37e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—GSTM1—stomach cancer	8.74e-06	7.29e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—ERBB2—stomach cancer	8.49e-06	7.08e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ERCC2—stomach cancer	8.22e-06	6.86e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—ALB—stomach cancer	7.95e-06	6.63e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CDKN1B—stomach cancer	7.86e-06	6.56e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—MTHFR—stomach cancer	7.72e-06	6.44e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—NOS3—stomach cancer	7.6e-06	6.34e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—CDKN1A—stomach cancer	7.25e-06	6.05e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—CAV1—stomach cancer	7.12e-06	5.94e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—APOA1—stomach cancer	7.11e-06	5.93e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—STAT3—stomach cancer	6.47e-06	5.4e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PPARG—stomach cancer	6.26e-06	5.23e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAPK3—stomach cancer	6.18e-06	5.16e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MYC—stomach cancer	6.02e-06	5.02e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—MAPK1—stomach cancer	5.88e-06	4.91e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—EGFR—stomach cancer	5.88e-06	4.91e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—ALB—stomach cancer	5.63e-06	4.7e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—KRAS—stomach cancer	5.56e-06	4.64e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—NOS3—stomach cancer	5.39e-06	4.5e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—PIK3CA—stomach cancer	5.11e-06	4.26e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PTGS2—stomach cancer	4.93e-06	4.11e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—HRAS—stomach cancer	4.72e-06	3.94e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Disease—IL6—stomach cancer	4.52e-06	3.77e-05	CbGpPWpGaD
Lenalidomide—PTGS2—Metabolism—PIK3CA—stomach cancer	4.28e-06	3.57e-05	CbGpPWpGaD
Lenalidomide—ABCB1—Metabolism—PIK3CA—stomach cancer	3.03e-06	2.53e-05	CbGpPWpGaD
